1 / 45

University of Jordan-Faculty of Pharmacy Department of Biopharmaceutics and Clinical Pharmacy

University of Jordan-Faculty of Pharmacy Department of Biopharmaceutics and Clinical Pharmacy Semester: First Course Title: Pharmacokinetics Course Code: 1203475 Prerequisite: Biopharmaceutics (1203471) Instructor: Dr. Mohammad Issa . Course Objectives :

matthewe
Télécharger la présentation

University of Jordan-Faculty of Pharmacy Department of Biopharmaceutics and Clinical Pharmacy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. University of Jordan-Faculty of Pharmacy Department of Biopharmaceutics and Clinical Pharmacy Semester: First Course Title: Pharmacokinetics Course Code: 1203475 Prerequisite: Biopharmaceutics (1203471) Instructor: Dr. Mohammad Issa

  2. Course Objectives : 1) Understanding mathematical background for modeling of the concentration time relationships for the different routes of administration. 2) Designing dosing regimens by relating plasma concentration of drugs to their pharmacological and toxicological action, 3) Understanding the concept of therapeutic drug monitoring for drugs with narrow therapeutic range or high toxicity.

  3. Learning Outcomes : A) Knowledge and understanding A1) Understanding mathematics of the time course of Absorption, Distribution, Metabolism, and Excretion (ADME) of drugs in the body. A2) Understanding Individualization of therapy and therapeutic drug monitoring. B) Intellectual skills (cognitive and analytical) B1) Utilization of mathematics of the time course of Absorption, Distribution, Metabolism, and Excretion (ADME) of drugs in the body for dosage optimization. B2) Developing dosing regimens for the individualization of therapy for the patient

  4. C) Subject specific skills C1) Fitting concentration time profiles and estimating pharmacokinetic parameters. C3) Designing dosing regimens in case of renal and hepatic dysfunction. D) Transferable Skills D1) Communicating the dosage adjustment with physicians. D2) Suggesting therapeutic monitoring plans. Teaching Methods : 1) Lectures 2) Computer software (demo) 3) Case Studies

  5. Tests & Evaluations : • Midterm exam 40% • Quizzes and HWs 10% • Final exam 50%

  6. 1. Introduction 2. The one-compartment open model with an intravenous bolus dose. Plasma data; elimination rate constant, AUC, elimination half-life, volume of distribution and clearance Urinary data; excretion rate constant and half-life, elimination rate constant 3. The one-compartment open model with an intravenous infusion. Continues infusion, Infusion with a bolus dose, post infusion 4. The one-compartment open model with absorption and elimination; Absorption rate constant, calculation of F, method of residuals, flip-flop kinetics 5. The one-compartment open model with multiple dosing kinetics; Multiple dosing IV and oral, multiple dosing factor, accumulation factor, loading dose, and average concentration. 6. Designing dosing regimens 7. Dosage adjustment in renal failure. (Aminoglycosides) 8. The two-compartment open model with intravenous administration. 9. Non-linear pharmacokintics Michaels-Mention kinetics, methods to obtain Vmax and Km (Phenytoin). 10. Pharmacodynamics Linear models, E-max and time dependent response. 11. Therapeutic Drug Monitoring. 12. Bioequivalence revisited.

  7. Textbook: Applied biopharmaceutics and pharmacokinetics Shargel and Yu, 5th edition, 2005 References: 1) Pharmacokinetics: processes, mathematics, and applications 2nd edition, Welling, P.G.., 1997 2) Handbook of Basic Pharmacokinetics Wolfgang Ritschel, 6th edition, 2004 3) Clinical pharmacokinetics: concepts and applications Rowland and Tozer, 3rd edition, 1995 Useful Web Sites 1) PHARMACOKINETICS LECTURE NOTES ONLINE http://www.healthsci.utas.edu.au/pharmacy/kinetics/main.htm 2) University of Alberta/ Dr. Jamali http://www.pharmacy.ualberta.ca/pharm415/contents.htm 3) A First Course in Pharmacokinetics and Biopharmaceutics http://www.boomer.org/c/p1/

  8. Pharmacokinetics: Introduction Dr Mohammad Issa

  9. What is pharmacokinetics?

  10. What is pharmacokinetics? • Pharmacokinetics is the study of kinetics of absorption, distribution, metabolism and excretion (ADME) of drugs and their corresponding pharmacologic, therapeutic, or toxic responses in man and animals’’ (American Pharmaceutical Association, 1972).

  11. Review of ADME processes • ADME is an acronym representing the pharmacokinetic processes of: A  Absorption D  Distribution M  Metabolism E  Excretion

  12. Review of ADME processes • Absorption is defined as the process by which a drug proceeds from the site of administration to the site of measurement (usually blood, plasma or serum) • Distribution is the process of reversible transfer of drug to and from the site of measurement (usually blood or plasma)

  13. Review of ADME processes • Metabolism is the process of a conversion of one chemical species to another chemical species • Excretion is the irreversible loss of a drug in a chemically unchanged or unaltered form • Metabolism and excretion processes represent the elimination process

  14. Applications of pharmacokinetics • bioavailability measurements • effects of physiological and pathological conditions on drug disposition and absorption • dosage adjustment of drugs in disease states, if and when necessary • correlation of pharmacological responses with administered doses • evaluation of drug interactions • clinical prediction: using pharmacokinetic parameters to design a dosing regimen and thus provide the most effective drug therapy

  15. Applications of pharmacokinetics Bioavailability measurements: Blood sulfadiazine concentration in human following the administration of a 3 g dose. A comparison of the behavior of microcrystalline sulfadiazine with that of regular sulfadiazine in human

  16. Applications of pharmacokinetics Effects of physiological and pathological conditions on drug disposition and absorption: plasma conc-time profile of cefepime after a 1000 mg IV infusion dose

  17. Applications of pharmacokinetics Using pharmacokinetic parameters to design a dosing regimen and thus provide the most effective drug therapy

  18. Rates and orders of reactions • The rate of a chemical reaction of process is the velocity with which the reaction occurs. Consider the following chemical reaction: • If the amount of drug A is decreasing with respect to time (that is, the reaction is going in a forward direction), then the rate of this reaction can be expressed as • Since the amount of drug B is increasing with respect to time, the rate of the reaction can also be expressed as • The rate of a reaction is determined experimentally by measuring the disappearance of drug A at given time intervals.

  19. Zero-Order Reactions • Consider the rate of elimination of drug A from the body. If the amount of the drug, A, is decreasing at a constant rate, then the rate of elimination of A can be described as: where k* is the zero-order rate constant. • The reaction proceeds at a constant rate and is independent of the concentration of A present in the body. An example is the elimination of alcohol

  20. Zero-Order Reactions • The amount of a drug with zero order elimination is described according to the following equation: where A is the amount of drug in the body, A0 is the amount of the drug at time zero (equal to the dose in the case of IV bolus)

  21. Drug with zero order PK A0 Slope = -K*

  22. Zero-Order Reactions: example • The administration of a 1000 mg of drug X resulted in the following concentrations:

  23. Zero-Order Reactions: example • What is the order of the elimination process (zero or first)? • What is the rate constant?

  24. Zero-Order Reactions: example

  25. Zero-Order Reactions: example • Since the decline in drug conc. Displayed a linear decline on normal scale, drug X has a zero order decline • From the equation displayed on the figure (intercept = 100, slope = -2.5) • The elimination rate constant is 2.5 mg/hr

  26. First-order Reactions • If the amount of drug A is decreasing at a rate that is proportional to A, the amount of drug A remaining in the body, then the rate of elimination of drug A can be described as: where k is the first-order rate constant • The reaction proceeds at a rate that is dependent on the concentration of A present in the body • It is assumed that the processes of ADME follow first-order reactions and most drugs are eliminated in this manner

  27. First-Order Reactions • The amount of a drug with first order elimination is described according to the following equation: where A is the amount of drug in the body, A0 is the amount of the drug at time zero (equal to the dose in the case of IV bolus) • This equation is equivalent to:

  28. Drug with first order PK

  29. Drug with first order PK: log transformation

  30. Nonlinear kinetics • Nonlinear pharmacokinetics is also known as dose-dependent and concentration dependent pharmacokinetics because the pharmacokinetic parameters are dependent on the drug concentration or the drug amount in the body • At least one of the absorption, distribution, and elimination processes, which affect the blood drug concentration—time profile, is saturable and does not follow first-order kinetics • The change in drug dose results in disproportional change in the blood drug concentration— time profile after single- and multiple-dose administrations

  31. Nonlinear kinetics

  32. Nonlinear kinetics Nonlinear kinetics: Linear kinetics:

  33. Linear vs nonlinear PK

  34. Laplace transformation Optional material

  35. Laplace transformation • The Laplace transform is a mathematical technique used for solving linear differential equations (apparent zero order and first order) and hence is applicable to the solution of many equations used for pharmacokinetic analysis.

  36. Laplace transformation procedure • Write the differential equation • Take the Laplace transform of each differential equation using a few transforms (using table in the next slide) • Use some algebra to solve for the Laplace of the system component of interest • Finally the 'anti'-Laplace for the component is determined from tables

  37. Important Laplace transformation (used in step 2) where s is the laplace operator, is the laplace integral , and X0 is the amount at time zero

  38. Anti-laplce table (used in step 4)

  39. Anti-laplce table continued (used in step 4)

  40. Laplace transformation: example • The differential equation that describes the change in blood concentration of drug X is: Derive the equation that describe the amount of drug X??

  41. Laplace transformation: example • Write the differential equation: • Take the Laplace transform of each differential equation:

  42. Laplace transformation: example • Use some algebra to solve for the Laplace of the system component of interest • Finally the 'anti'-Laplace for the component is determined from tables

  43. Laplace transformation: example • The derived equation represent the equation for a zero order elimination

More Related